-
Innovation Ranking
Innovation Ranking – GD Power Development Co Ltd
GD Power Development Co Ltd (GD Power) is an electric power generation and distribution company. It generates electricity through thermal, wind, hydro, gas, coal, chemical, and photovoltaic sources. The company also produces and supplies coal and chemical products; and provides services such as industrial development, technological innovation, energy saving and environmental protection, and management innovation. GD Power distributes electric power to industrial, commercial and household consumers. It has an operational presence across China. GD Power is headquartered in Chaoyang, Beijing,...
-
Product Insights
Gansu Dingxi Tongwei Wind Farm-GD Power, China
Empower your strategies with our Gansu Dingxi Tongwei Wind Farm-GD Power report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the project’s core details and stages of development.....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – WP-1302 in Graves Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - WP-1302 in Graves Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. WP-1302 in Graves Diseases Drug Details: WP-1302 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GD2-SADA in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GD2-SADA in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GD2-SADA in Melanoma Drug Details: Monoclonal antibody conjugate is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GD2-SADA in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GD2-SADA in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GD2-SADA in Small-Cell Lung Cancer Drug Details: Monoclonal antibody conjugate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GD2-SADA in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GD2-SADA in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GD2-SADA in Sarcomas Drug Details: Monoclonal antibody conjugate is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GD2-SADA in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GD2-SADA in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GD2-SADA in Solid Tumor Drug Details: Monoclonal antibody conjugate is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Emphysema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Cryoglobulinemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Cryoglobulinemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Cryoglobulinemia Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Graft Versus Host Disease (GVHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Graft Versus Host Disease (GVHD) Drug...